ArticleOPEN ACCESS

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

Blood Advances
DOI: 10.1182/bloodadvances.2023010132
8Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Syrykh, C., Pons-Brun, B., Russiñol, N., Playa-Albinyana, H., Baumann, T., Duran-Ferrer, M., … Nadeu, F. (2023, December 12). IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Blood Advances. American Society of Hematology. https://doi.org/10.1182/bloodadvances.2023010132

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free